VIVO Cannabis Inc. (V:VIVO*CA)

Business Focus: N/A

Apr 03, 2023 07:00 am ET

MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio

BARRIE, ON, April 3, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") are pleased to announce the completion of the previously announced plan of arrangement under section 192 of the Canada Business Corporations Act (the "Arrangement"), pursuant to which MediPharm has acquired all of the issued and outstanding common shares of VIVO (the "VIVO Shares") in an all-equity business combination transaction effective April 1, 2023 (the "Effective Time"). The Arrangement combines two h

Mar 28, 2023 07:27 am ET

VIVO Cannabis Announces Fourth Quarter 2022 Results

Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter.

Mar 24, 2023 03:15 am ET

VIVO Cannabis Obtains Final Court Order Approving Its Plan of Arrangement with MediPharm

Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce that it has obtained a final court order (the "Final Order") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the "Arrangement") with MediPharm Labs Corp. ("MediPharm") under the Canada Business Corporations Act. As previously announced, the Arrangement was approved at the special meeting of the shareholders of VIVO held on March 21, 2023.

Mar 21, 2023 10:26 pm ET

VIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce that, at the special meeting of the shareholders of VIVO (the "Shareholders") held today (the "Meeting"), the Shareholders approved (i) a special resolution (the "Arrangement Resolution") authorizing a plan of arrangement under section 192 of the Canada Business Corporations Act (the "Arrangement"), previously announced on December 22, 2022, pursuant to which MediPharm Labs Corp. ("MediPharm") will acquire all of the issued and outstanding common shares of VIVO (each, a "Share") in an all-equity business combination transaction, and (ii) a special resolution (the "Reduction of Stated Capital Resolution") authorizing a related reduction in the stated capital of the Shares. Details of the voting results will be filed under VIVO's profile on SEDAR at www.sedar.com.

Feb 17, 2023 06:35 pm ET

VIVO Cannabis Inc. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with MediPharm Labs Corp.

TORONTO, Feb. 17, 2023 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") is pleased to announce the mailing of a joint management information circular of VIVO and MediPharm Labs Corp. ("MediPharm") dated February 6, 2023 (the "Circular") and related documents for the special meeting of VIVO shareholders to be held virtually at 11:00 a.m. (Toronto time) on March 21, 2023 (the "Meeting"). The Meeting is being held in connection with the previously announced plan of arrangement under section 192 of the Canada Business Corporations Act, whereby MediPharm will acquire all of the issu

Dec 22, 2022 08:45 am ET

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

Barrie, Ontario--(Newsfile Corp. - December 22, 2022) - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") today announced that MediPharm and VIVO have entered into a definitive arrangement agreement (the "Arrangement Agreement") whereby MediPharm has agreed to acquire VIVO in an all-equity business combination transaction (the "Transaction"). The Transaction is expected to combine two highly complementary businesses, creating a unique and market differentiating international medical cannabis leader. Upon the completion of the Transaction, existing MediPharm shareholders are expected to own between 65% and 79% of the combined company resulting from the Transaction (the "Combined Company") and VIVO shareholders are expected to own between 35% and 21% of the Combined Company.

Dec 22, 2022 08:14 am ET

IIROC Trade Resumption - VIVO

TORONTO, Dec. 22, 2022 /CNW/ - Trading resumes in:

Dec 22, 2022 07:45 am ET

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with over $50M in annualized revenue, based on Q3 2022.(1)(2)(3)(4)Pro-forma Combined Company is expected to have positive EBITDA(5) synergies of between $7M to $9M on an annualized basis within 12 months closing of the Transaction.(1)(2)(3)(4)Transaction is expected to accelerate MediPharm Labs' path to profitability, with possibility to reach positive EBITDA(5) and cash flow targeted in the fi

Dec 22, 2022 07:28 am ET

IIROC Trading Halt - VIVO

TORONTO, Dec. 22, 2022 /CNW/ - The following issues have been halted by IIROC:

Nov 14, 2022 10:55 pm ET

VIVO Cannabis Announces Third Quarter 2022 Results

Toronto, Ontario--(Newsfile Corp. - November 14, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its third quarter 2022 financial and operating results.

Oct 03, 2022 07:00 am ET

VIVO Cannabis Announces Third Supplemental Debenture Indenture

Toronto, Ontario--(Newsfile Corp. - October 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that, further to the Company's news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the "Supplemental Indenture") with TSX Trust Company ("TSXT") in respect of its outstanding unsecured convertible debentures in the aggregate principal amount of $5,546,808 (collectively, the "Debentures"). The Supplemental Indenture amends the debenture indenture dated February 28, 2018 between the Company and TSXT, as amended and supplemented by a first supplemental debenture dated April 24, 2020 and a second supplemental debenture indenture dated September 15, 2020.

Sep 19, 2022 08:00 am ET

VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the "Debentures") to amend the terms of the Debentures (the "Amendments").

Aug 15, 2022 06:26 pm ET

VIVO Cannabis Announces Second Quarter 2022 Results

Net revenue for Q2 2022 was $5.2 million

Jul 22, 2022 07:30 am ET

VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada

Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced that Canna Farms has received a Research Licence from Health Canada allowing it to possess cannabis for the purpose of research. The Research Licence allows Canna Farms to evaluate its medical cannabis products based on taste, smell, feel and visual appeal for research purposes prior to sales of these products.

Jul 02, 2022 12:16 am ET

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting").

Jun 03, 2022 07:30 am ET

VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients

Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The publication, entitled "Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study" was published in the peer-reviewed journal Psychiatry Research and was completed by VIVO's Harvest Medicine Inc ("HMED") subsidiary. To the Company's knowledge, it is the largest study to date of its kind, examining the impact of medical cannabis using longitudinal data and completed validated questionnaires for anxiety (GAD-7) and depression (PHQ-9) in 7,362 Canadian patients. Analyses were conducted for three different timepoints: 3-6 months, 12-18 months, and 24 months or greater.

May 16, 2022 10:00 pm ET

VIVO Cannabis Announces First Quarter 2022 Results

Toronto, Ontario--(Newsfile Corp. - May 16, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its first quarter 2022 financial and operating results.

Mar 31, 2022 07:57 am ET

VIVO Cannabis Announces Fourth Quarter 2021 Results

Toronto, Ontario--(Newsfile Corp. - March 31, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its fourth quarter 2021 financial and operating results.

Feb 11, 2022 07:00 am ET

VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace

Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced a partnership with Cicatrix Labs Ltd. ("Cicatrix Labs") to offer Assuage™ vaginal and rectal suppositories on VIVO's Canna Farms e-commerce marketplace.

Dec 21, 2021 07:30 am ET

VIVO Cannabis(TM) Announces Appointment of Former President and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board

Toronto, Ontario--(Newsfile Corp. - December 21, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Shai Altman and Glen Huber to the board of directors of the Company (the "Board"), effective immediately.

Nov 23, 2021 05:30 pm ET

VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program

Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical™ brand.

Nov 19, 2021 07:32 pm ET

VIVO Cannabis(TM) Supports Patients and Hope Community During BC Flooding

Toronto, Ontario--(Newsfile Corp. - November 19, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today provided an update on the recent flooding situation affecting Southern British Columbia.

Nov 15, 2021 09:44 pm ET

VIVO Cannabis(TM) Announces Third Quarter 2021 Results

Toronto, Ontario--(Newsfile Corp. - November 15, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its third quarter 2021 financial and operating results.

Nov 03, 2021 05:00 pm ET

VIVO Cannabis(TM) Announces Launch of New Lumina(TM) Products

Toronto, Ontario--(Newsfile Corp. - November 3, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of new products under its Lumina™ health and wellness brand.

Oct 21, 2021 07:30 am ET

VIVO Cannabis(TM) Completes First Shipment of EU-GMP Medical Grade Cannabis to Beacon Medical Germany GmbH

Toronto, Ontario--(Newsfile Corp. - October 21, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading medical cannabis company and holder of licenses under the Cannabis Act through its wholly owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann Medicinals"), today announced that its EU-GMP licensed subsidiary ABcann Medicinals has successfully completed its first shipment of EU-GMP certified Canadian dried flower medical cannabis into Europe.

Oct 06, 2021 06:00 pm ET

VIVO Cannabis(TM) Adds Craft Licensed Producer, Delta 9 to Online Medical Marketplace

Toronto, Ontario--(Newsfile Corp. - October 6, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced a partnership with Delta 9 Cannabis Inc ("Delta 9") to offer Delta 9 products on VIVO's Canna Farms e-commerce marketplace.

Aug 25, 2021 07:30 am ET

VIVO Cannabis(TM) Provides Strategic Update for a Medical Cannabis Focus

Toronto, Ontario--(Newsfile Corp. - August 25, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann Medicinals" or "ABcann"), today provides some additional information for its shareholders regarding the Company's future strategic focus.

Aug 16, 2021 07:10 pm ET

VIVO Cannabis(TM) Announces Second Quarter 2021 Results

Net revenue of $6.4 million - an increase of 16% over Q1 2021

Aug 10, 2021 07:30 am ET

VIVO Cannabis(TM) Adds Craft Licensed Producer Truro Cannabis to Online Medical Marketplace

Toronto, Ontario--(Newsfile Corp. - August 10, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced the launch of Truro Cannabis products on VIVO's Canna Farms e-commerce marketplace.

Jul 29, 2021 07:30 am ET

VIVO Cannabis(TM) Subsidiary, Beacon Medical Germany GmbH, Receives First Permit to Import Medical Cannabis from Canada into Germany

Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced that its EU-GMP/GDP licensed subsidiary Beacon Medical Germany GmbH, has received its first import permit from Germany's BfArM, the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte), allowing the import of Canadian grown dried flower medical cannabis from VIVO's ABcann Medicinal affiliate's GMP-certified Napanee, Ontario site, into Europe.

Jul 22, 2021 07:30 am ET

VIVO Cannabis(TM) Launches Canna Farms(TM) Brick Hash and Large Format Pink Kush Flower to Online Medical Marketplace

Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced the launch of Canna Farms™ Brick Hash, a premium, all natural, solventless concentrate that can be consumed by inhalation or as an edible. Hashish, or hash is made by extracting the resin from cannabis plants and pressing it into a solid form.

Jul 05, 2021 05:32 pm ET

VIVO Cannabis(TM) Announces Results of 2021 AGM and Election of New Directors

Toronto, Ontario--(Newsfile Corp. - July 5, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting").

Jul 05, 2021 07:45 am ET

VIVO Announces Board Changes

Annual and Special Meeting Proceeding as Scheduled

Jun 03, 2021 04:30 pm ET

VIVO Cannabis(TM) Launches Premium Topical CBD Cream Infused with Terpenes: Unique Formulation Designed for Medical Users

Toronto, Ontario--(Newsfile Corp. - June 3, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced the launch of Beacon Medical™ Extra Strength CBD|T Cream, an innovative, premium cannabis topical cream for Canadian medical patients. With 500 mg of cannabidiol (CBD) per 50-gram unit, in a proprietary formulation that includes carefully curated ingredients with anti-oxidant, anti-inflammatory, and analgesic properties, together with skin penetration enhancers, Beacon Medical™ Extra Strength CBD|T Cream is designed using "entourage" principles to achieve synergies of bioactive ingredients and provide optimal symptom relief for medical conditions.

May 17, 2021 06:20 pm ET

VIVO Cannabis™ Announces First Quarter 2021 Results

Net revenue of $5.5 million – a decrease of 11% over Q4 2020 Vanluven facility received EU-GMP certification allowing VIVO to export cannabis products for sale in Europe and Beacon Medical Germany GmbH received an import license to allow imports of medical cannabis Released brick hash as part of VIVO's Cannabis 2.0 product lineup and expect to release a new line of topicals in Q2 2021, VIVO's 9th and 10th product formats, respectively Closed an $8 million equity offering in February 2021, including the full exercise of the over-allotment option TORONTO, May 17, 2021 /CNW/ - VIVO Cannabis In

Apr 15, 2021 07:00 am ET

VIVO Cannabis™ Announces Appointment of Ray Laflamme to the Board

TORONTO, April 15, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Ray Laflamme to the board of directors of the Company (the "Board"), effective as of April 12, 2021.

Mar 31, 2021 11:17 pm ET

VIVO Cannabis™ Announces Fourth Quarter 2020 Results

Net revenue for Q4 2020 was $6.2 million; Net revenue for 2020 was $32.8 million, an increase of over 32% compared with the same period last yearRecorded first significant revenues from VIVO's Australian business in 2020In October 2020, began streamlining its Napanee, Ontario operations and integrating the operations of its Napanee and Hope LP's to achieve production cost and efficiency improvements. Subsequent to year end:

Mar 17, 2021 03:47 pm ET

VIVO Cannabis Announces Date for Fourth Quarter 2020 Results

NAPANEE, ON, March 17, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company will release its fourth quarter 2020 results on Tuesday, March 30, 2021, after the close of markets.

Mar 11, 2021 06:22 am ET

VIVO Announces EU-GMP Certification

NAPANEE, ON, March 11, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that its Vanluven facility in Napanee Ontario has received EU-GMP (European Union Good Manufacturing Practices) certification from Germany's Brandenburg health authority, the Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit ("LAVG"). The certification takes effect immediately and enables VIVO, through its ABcann Medicinals subsidiary, to export product for sale into European and other markets requiring products to be manufactured under the rigorous GMP sta

Feb 26, 2021 08:59 am ET

VIVO Cannabis™ Announces Closing of $8 Million Overnight Marketed Public Offering Including Full Exercise of Over-Allotment Option

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Feb 23, 2021 07:58 am ET

VIVO Cannabis™ Prices $7 Million Overnight Marketed Public Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Feb 22, 2021 04:04 pm ET

VIVO Cannabis™ Announces Overnight Marketed Public Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Jan 04, 2021 06:00 am ET

VIVO Cannabis™ Announces Entry into Quebec and Provides Adult-Use Business Update

TORONTO, Jan. 4, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced its products have entered into the Quebec market with Canna Farms™ BC Kief as the province's first in the kief category. The Company also provided an update on its adult-use cannabis products across Canada.

Dec 31, 2020 04:45 pm ET

VIVO Announces Stock Option Grants

NAPANEE, ON, Dec. 31, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO), (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that in conjunction with its annual employee compensation program, it has granted, effective today, an aggregate of 6,900,000 million stock options (each, an "Option") to certain officers, employees and consultants of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $0.13 per Share, being the closing price of the Shares on the TSX on December 30,

Dec 16, 2020 06:00 am ET

VIVO Cannabis™ Provides Medical Cannabis Business Update

TORONTO, Dec. 16, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to provide an update on its medical cannabis business.

Nov 30, 2020 06:00 am ET

VIVO Cannabis™ Announces Board and Leadership Changes

TORONTO, Nov. 30, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), announced today that both Paul Lucas, Chair and Barry Fishman, Chief Executive Officer and Director, will be retiring from the Company effective December 31, 2020.

Nov 12, 2020 09:36 pm ET

VIVO Cannabis™ Announces Third Quarter 2020 Results

Net revenue for Q3 2020 was $7.5 million and Q3 2020 year-to-date net revenue was $25.1 million, an increase of over 50% compared with the same period last yearRestructured $27 million in current liabilities, and extended remaining 6% convertible debt of $6.6 million to September 15, 2022 Streamlined and consolidated operations expected to result in increased economies of scale and expected cost savings of over $1 million per quarter Completed largest harvest in VIVO's history in Napanee, Ontario Delivered first product shipment to Medical Cannabis by Shoppers™ TORONTO, Nov. 12, 2020 /CNW/

Nov 02, 2020 04:00 pm ET

VIVO Cannabis to Host Conference Call for Third Quarter 2020 Results

NAPANEE, ON, Nov. 2, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced it will release its third quarter 2020 results on Thursday, November 12, 2020, after the close of markets. VIVO will also host a conference call on Friday, November 13, 2020 at 10 a.m. ET to discuss the Company's third quarter 2020 results. Barry Fishman, CEO and Michael Bumby, CFO, will host the call.

Oct 20, 2020 08:00 am ET

VIVO Cannabis™ Streamlines Operations

Rightsizing of Napanee Organization

Oct 16, 2020 07:00 am ET

VIVO Cannabis™ Withdraws $5 Million Offering and Provides Business Update

TORONTO, Oct. 16, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") announced today that it is terminating a planned offering of $5.1 million, which it had previously announced on October 6, 2020.

Oct 07, 2020 08:06 am ET

IIROC Trade Resumption - VIVO

TORONTO, Oct. 7, 2020 /CNW/ - Trading resumes in:

Oct 06, 2020 04:06 pm ET

VIVO Cannabis™ Announces Fully Marketed $5 Million Public Offering

VIVO Cannabis Inc. (TSX:VIVO) (“VIVO” or the “Company”) is pleased to announce that it has commenced a best efforts fully marketed offering of units of the Company (each, a “Unit” and, collectively, the “Units”) at an issue price per Unit of $0.15,...

Oct 06, 2020 03:30 pm ET

IIROC Trading Halt - VIVO

TORONTO, Oct. 6, 2020 /CNW/ - The following issues have been halted by IIROC:

Oct 06, 2020 07:00 am ET

VIVO Cannabis™ Announces Approval of $50 Million Base Shelf Prospectus

TORONTO, Oct. 6, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") announces that it has filed a short form base shelf prospectus (the "Shelf Prospectus") with securities regulatory authorities in each province of Canada.

Oct 05, 2020 07:00 am ET

VIVO Cannabis™ Begins Largest Harvest in Company's History

TORONTO, Oct. 5, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it has begun its 2020 season harvest at its Kimmetts facility in Napanee, Ontario, the largest in the Company's history.

Sep 29, 2020 05:00 pm ET

VIVO Cannabis™ to Present at the Virtual Gravitas Healthcare Investor Day

TORONTO, Sept. 29, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that Barry Fishman, VIVO's CEO, will present an overview of the Company at the Gravitas Healthcare Investor Day on Thursday, October 1, 2020 at 2:30 p.m. ET.

Sep 24, 2020 07:00 am ET

VIVO Cannabis™ Completes Debenture Refinancing

TORONTO, Sept. 24, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that it has completed its previously announced partial prepayment, conversion and amendment of unsecured convertible debentures (the "Debentures").

Sep 16, 2020 07:00 am ET

VIVO Cannabis™ Announces Agreement to Amend Outstanding Debentures

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE/

Aug 17, 2020 07:00 am ET

/R E P E A T -- VIVO Cannabis™ Announces Second Quarter 2020 Results/

Net revenue of $9.4 million – an increase of 15% over Q1 2020 and 79% over Q2 2019Achieved 68% Ontario retail market share in the concentrates category, including first-to-market shatter by Fireside™ XEntered product supply and clinical services agreements with Medical Cannabis by Shoppers™Canna Farms™ is the fourth most recognized cannabis brand, according to recent Brightfield Group independent surveyLargest export shipment to Australia occurred during the quarter TORONTO, Aug. 14, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its seco

Aug 14, 2020 05:00 pm ET

VIVO Cannabis™ Announces Second Quarter 2020 Results

Jul 27, 2020 05:00 pm ET

VIVO Cannabis to Host Conference Call for Second Quarter 2020 Results

NAPANEE, ON, July 27, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that senior management will host a conference call on Monday, August 17, 2020 at 11 a.m. ET to discuss the Company's second quarter 2020 results.

Jul 06, 2020 07:00 am ET

VIVO Advances Several Medical Cannabis Initiatives

NAPANEE, ON, July 6, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc. ("ABcann") and Harvest Medicine Inc. ("Harvest Medicine"), is pleased to provide an update on its global medical business, which operates in Canada, Germany and Australia.

Jun 29, 2020 07:00 am ET

VIVO Cannabis™ Provides Adult-Use Product Update

Canna Farms captures 68% of extracts market share with Ontario retailers

Jun 24, 2020 07:00 am ET

VIVO Enters into Two Agreements with Medical Cannabis by Shoppers™

NAPANEE, ON, June 24, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") and its subsidiaries have entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers™.

Jun 22, 2020 07:00 am ET

VIVO CANNABIS™ Expands Cultivation and Processing Capacity

NAPANEE, ON, June 22, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. ("NCC"), has begun commercial production in its ethanol extraction suite.

Jun 19, 2020 07:00 am ET

VIVO Cannabis™ Enters Into New Supply Agreement With Medipharm Labs Australia

NAPANEE, ON, June 19, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO), (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that its subsidiary, Beacon Medical Australia Pty. Ltd. ("Beacon Medical Australia"), entered into an agreement with MediPharm Labs Australia Pty. Ltd. ("MediPharm Labs Australia"), a subsidiary of MediPharm Labs Corp. (TSX: LABS) ("MediPharm Labs"), whereby MediPharm Labs Australia will supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia to sell into the Australian market.

Jun 18, 2020 05:00 pm ET

VIVO Cannabis™ Announces Filing of Preliminary Base Shelf Prospectus

Also Announces Termination of Automatic Securities Disposition Plan

May 28, 2020 05:33 pm ET

VIVO Cannabis™ Announces Results of 2020 AGM and Election of New Director

NAPANEE, ON, May 28, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that each of the seven individuals nominated for election as a director of VIVO at the Company's Annual General and Special Meeting of Shareholders (the "Meeting") held on May 28, 2020 were elected. Management nominated each of the existing directors, together with new nominee, Christie Henderson, for election at the Meeting.

May 14, 2020 06:15 pm ET

VIVO Cannabis™ Announces First Quarter 2020 Results

Net revenue was $8.2 million, an increase of 24% over Q4 2019

May 11, 2020 07:00 am ET

VIVO Cannabis to Host Conference Call for First Quarter 2020 Results

NAPANEE, ON, May 11, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that senior management will host a conference call on Friday, May 15, 2020 at 10 a.m. ET to discuss the Company's first quarter 2020 results.

Apr 03, 2020 07:00 am ET

VIVO Cannabis™ Announces Partial Debenture Repurchase

NAPANEE, ON, April 3, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") announces that it has re-purchased for cancellation certain of its outstanding 6.0% unsecured convertible debentures (each, a "Debenture"), in the aggregate principal amount of $10 million, for a purchase price of $9.3 million (plus accrued and unpaid interest thereon), representing a 7% discount to the face value, pursuant to an agreement with the holder thereof (the "Holder"). As a result of the repurchase, the Company now has Debentures in the aggregate principal amount of $24.5 milli

Mar 30, 2020 05:55 pm ET

VIVO Cannabis™ reports fourth quarter and full year 2019 results

139% year-over-year increase in revenue, with 7% increase in SG&A expenses

Mar 27, 2020 03:25 pm ET

VIVO Cannabis to Host Conference Call for Fourth Quarter 2019 Results

Mar 20, 2020 09:28 am ET

VIVO Cannabis™ provides Update Regarding COVID-19

NAPANEE, ON, March 20, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced the Company, its production facilities and medical clinics are continuing to respond to COVID-19 with changes to internal business practices consistent with the guidelines of public health authorities. As VIVO continues to monitor the COVID-19 pandemic, the health and safety of its customers and employees remains the Company's top priority.

Mar 02, 2020 06:00 am ET

VIVO Chair, Paul Lucas, Receives Lifetime Achievement Award

NAPANEE, ON, March 2, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is proud to congratulate the chair of its board of directors, Paul Lucas, on his receipt of the 2020 Lifetime Achievement Award from Life Sciences Ontario. This award is in recognition of Mr. Lucas' exceptional leadership and contributions to the development of the life sciences sector in Canada, his commitment to the community and his passion for improving the quality of life for Canadians.

Feb 07, 2020 08:00 am ET

TMX Group Equity Financing Statistics - January 2020

Toronto Stock Exchange, TSX Venture Exchange

Feb 03, 2020 09:00 am ET

View from the C-Suite: Barry Fishman, Chief Executive Officer, VIVO Cannabis Inc., tells his company's story. Filmed on January 24, 2020

TORONTO, Feb. 3, 2020 /CNW/ -

Jan 24, 2020 10:04 am ET

VIVO Cannabis Inc. Opens the Market

TORONTO, Jan. 24, 2020 /CNW/ - Barry Fishman, Chief Executive Officer, VIVO Cannabis Inc. (VIVO), joined Dani Lipkin, Innovation Sector Head, Capital Formation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Based in Napanee, Ontario, VIVO is a cannabis company that holds production and sales licenses from Health Canada and operates indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of brands, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. VIVO Cannabis Inc. graduated and commenced trading on Toronto Stock Exc

Jan 23, 2020 06:00 am ET

VIVO Announces Trading Date for TSX Graduation and Provides Cannabis 2.0 Update

NAPANEE, ON, Jan. 23, 2020 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce its common shares (the "Common Shares") will begin trading on the Toronto Stock Exchange (the "TSX") effective as of market open on January 24, 2020, under the current trading symbol of VIVO. In conjunction with the TSX listing, the Common Shares will be voluntarily delisted from the TSX Venture Exchange.

Dec 20, 2019 06:00 am ET

VIVO Cannabis Inc. Announces Cannabis 2.0 Products

NAPANEE, ON, Dec. 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today officially revealed its new Cannabis 2.0. products set to come to market in the coming months across Canada. VIVO will focus on the vape, chocolates and concentrates categories leveraging VIVO's premium adult-use cannabis brands including Canna Farms™ and Fireside™.

Dec 12, 2019 06:00 am ET

VIVO Announces Stock Option Grants

NAPANEE, ON, Dec. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that it has granted, effective today, an aggregate of 3,364,500 stock options (each, an "Option") to certain directors, officers, employees and consultants of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $0.215 per Share, being the closing price of the Shares on the TSX Venture Exchange on December 11, 2019, for a period of five years from th

Nov 14, 2019 03:40 pm ET

VIVO Cannabis™ Reports Third Quarter 2019 Results

Net revenue was $6.3 million in the quarter, a 19% increase, quarter-over-quarter, and 175% increase over Q3 2018, and $16.6 million year-to-date, a 328% increase over the same period last year. Adjusted EBITDA(1) was ($2.1) million in Q3 2019 compared to ($1.2) million in Q2 2019, primarily attributable to one-time expenses, including the ramp-up of new licenced capacity. Healthy balance sheet with $50.1 million in cash and cash equivalents and $6.1 million in strategic investments. Maintained leadership pricing of $7.15 per gram of dry flower in Q3 2019 (compared with $6.96 in Q2 2019), wi

Nov 12, 2019 06:00 am ET

VIVO Cannabis Receives Conditional Approval to Graduate to the Toronto Stock Exchange

NAPANEE, ON, Nov. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its common shares on the TSX.

Nov 01, 2019 03:00 pm ET

VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call

NAPANEE, ON, Nov. 1, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that senior management will host a conference call to discuss the Company's third quarter 2019 results. The Company will release its results for the third quarter on Thursday, November 14, 2019, after the close of markets.

Oct 29, 2019 07:30 am ET

VIVO and CB2 Insights Enter Technology and Research Partnership

Partnership to focus on implementing a medical product development strategy for VIVO's global medical cannabis offering, utilizing CB2 Insights' leading technology platform Sail and research capabilities Joint venture will aim to increase the collection of real word data to assist health care stakeholders in making informed decisions on new cannabis-based treatments for patients In collaboration, VIVO and CB2 Insights will look to uncover data trends and insights from Canada that will help inform ventures in the international marketplace TORONTO, Oct. 29, 2019 /CNW/ - CB2 Insights Inc. (CSE

Oct 03, 2019 08:09 am ET

VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans

Announcements made during VIVO's Analyst and Investor Day Held at Napanee Operations

Sep 17, 2019 07:00 am ET

VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe

Linneo Health Receives EU-GMP Certification

Aug 28, 2019 07:12 pm ET

VIVO Cannabis™ Reports Q2 2019 Financial and Operating Results

Net revenue was $5.3 million in the quarter, a five-fold increase over the same quarter last year.Cultivation license was granted in the third quarter of 2019 for four new seasonal greenhouses in Napanee Ontario, increasing VIVO's annualized cultivation capacity by 4,000 kilograms and contributing to its innovative low-cost capacity plan to supply a broad line of products, including cannabis infused edibles, topicals and beverages.Current licensed internal cultivation capacity now totals 12,000 kilograms and agreements are in place with two licensed third-party cultivators to supply approxim

Aug 15, 2019 11:51 am ET

VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call

NAPANEE, ON, Aug. 15, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that senior management will host a conference call to discuss the Company's second quarter 2019 results. The Company will release its results for the second quarter on Wednesday, August 28, 2019, after the close of markets.

Aug 13, 2019 11:31 am ET

The Cannabis ETF (THCX) Rebalance Further Diversifies Portfolio

NEW YORK, Aug. 13, 2019 /PRNewswire/ -- Innovation Shares, a provider of thematic ETFs, announced it has completed the monthly rebalance of The Cannabis ETF (NYSE: THCX) and has added four companies to the portfolio: Valens GroWorks Inc. (TSXV: VGW), EnWave Corp. (TSXV: ENW), cbdMD Inc. (NYSE: YCBD) and Fire & Flower Holdings (TSX: FAF). Concurrently, three companies were removed from the portfolio: CannTrust Holdings (NYSE: CTST), Vivo Cannabis (TSXV: VIVO) and Innovative Industrial Properties (NYSE: IIPR).

Aug 06, 2019 07:00 am ET

VIVO Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses

NAPANEE, ON, Aug. 6, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation licence from Health Canada for its Kimmetts facility. Kimmetts, an innovative seasonal greenhouse site in Napanee, Ontario, is VIVO's third licensed production facility. Phase 1 of the planned development of Kimmetts includes four positive-pressure airhouse structures with 86,000 square feet of cultivation space. The new site will increase the Company's annualized

Jul 30, 2019 07:00 am ET

VIVO Commences Extraction Operations in Napanee, Ontario

NAPANEE, ON, July 30, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received approval from Health Canada to commence extraction operations using its on-site super-critical CO2 extraction system.

Jun 20, 2019 07:00 am ET

VIVO Announces Strategic Investment in Friendly Stranger

NAPANEE, ON, June 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has made a $1.25 million strategic investment in Friendly Stranger Holdings Corp. ("Friendly Stranger"), a longstanding retail champion of cannabis culture. The investment is intended to facilitate Friendly Stranger's aggressive cannabis retail expansion plans, with a goal of bringing multiple retail stores to the Canadian market.

Jun 12, 2019 05:00 pm ET

VIVO Completes First Canadian Installation of Innovative Airhouses in Napanee

NAPANEE, ON, June 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received notification that its Kimmetts project has now advanced to the second phase of Health Canada's review and approval process. Kimmetts is being developed as a hybrid outdoor cultivation site, which currently houses four Airstream InnovationsTM environmental control shelters with 86,000 square feet of cultivation space.

Jun 05, 2019 01:00 pm ET

VIVO Cannabis™ Reports Results of 2019 AGM

NAPANEE, ON, June 5, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited and ABcann Medicinals Inc., and its medical cannabis clinic network operated by Harvest Medicine Inc., today announced the results of its annual general and special meeting of shareholders held on June 4, 2019 (the "Meeting").

May 29, 2019 05:05 pm ET

VIVO Cannabis™ Reports Q1 2019 Financial Results

Net revenue of $5.1 million, compared to $5.8 million in Q4 2018 – Q4 2018 sales benefited from initial product stocking by provincial distributorsAdjusted EBITDA of ($2.2M), compared to ($7.3M) in Q4 2018Cash and short-term investments (excluding strategic equity investments) of $68.4 million as at March 31, 2019Net selling price of VIVO's premium cannabis dry flower products was $7.70 per gram (top-tier in the industry), up from $7.51 in Q4 2018B.C. and Ontario facility expansions received Health Canada approval in March 2019 and are expected to add over 4,000 kilograms per year of premium

May 22, 2019 05:00 pm ET

VIVO Cannabis Signs Australian Distribution Agreement

NAPANEE, ON, May 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has signed a distribution agreement with Burleigh Heads Cannabis Pty Ltd. ("Burleigh Heads"), one of Australia's leading medicinal cannabis distributors. The agreement is expected to increase the ability of Australian patients to access VIVO's high-quality medicinal cannabis flower, oil and other products via approved channels.

May 22, 2019 07:00 am ET

Vivo Cannabis™ to report Q1 2019 results on May 29, 2019

Also Announces Change of AGM Venue

May 21, 2019 07:40 pm ET

VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical Cannabis Platform

NAPANEE, ON, May 21, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), through its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), today announced the addition of GTEC Holdings Ltd. (TSX-V:GTEC) (OTC:GGTTF) (FRA:1BUP), sold under the brand GreenTec™, to the list of licensed producers selling product on its medical cannabis platform.

May 10, 2019 07:30 am ET

Canna Farms Expands Sales to Alberta

HOPE, BC, May 10, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), has completed registration with Alberta Gaming, Liquor & Cannabis ("AGLC") to supply the Province of Alberta with its well-recognized premium cannabis products. Canna Farms is preparing its first shipments for immediate delivery to AGLC.

Apr 30, 2019 07:00 am ET

VIVO Cannabis™ announces significant revenue growth for 2018

2018 gross and net revenue of $13.3 and $9.7 million, respectively2018 pro-forma gross and net revenue of $22.7 and $17.3 million, respectively, which includes acquired companies for all of 2018Q4 2018 gross and net revenue of $8.1 and $5.8 million, respectively, a 152% increase compared to net revenue in Q3 20182018 year-end cash and short-term investments (excluding strategic equity investments) of $74.8 million

Apr 25, 2019 07:00 am ET

VIVO Cannabis™ initiates additional facility expansion in B.C.

HOPE, BC, April 25, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") today announced its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), has received local municipal approval for its Phase 5 expansion which will add an incremental 2,500 kilograms of indoor capacity to its facility in Hope, B.C.

Apr 10, 2019 03:29 pm ET

VIVO Cannabis™ to Report Fourth Quarter and Full Year 2018 Financial and Operating Results

NAPANEE, ON, April 10, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets, today announced the Company expects to issue fiscal fourth quarter and full year 2018 financial and operating results before the markets open on April 30, 2019.

Apr 09, 2019 08:30 am ET

The Most Prevalent Cannabis E-commerce Platforms in Canada

Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures. However, given that only two of Canada's ten provinces—Manitoba and Saskatchewan—currently allow...

Apr 04, 2019 08:00 am ET

Canada Prepares for 420: Canadian Cannabis Companies Establishing an Online Presence

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks concludes our two part series looking at the Canadian cannabis landscape and the numerous companies ensuring not only a brick and mortar footprint, but also...

Mar 22, 2019 03:06 pm ET

IIROC Trading Resumption - VIVO

VANCOUVER, March 22, 2019 /CNW/ - Trading resumes in:

Mar 22, 2019 02:52 pm ET

VIVO Cannabis™ announces Health Canada approval for Hope expansion, doubling production capacity in British Columbia

NAPANEE, ON, March 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, Canna Farms Ltd. ("Canna Farms"), has received approval from Health Canada to begin cultivation in the expansion of its Yale Road facility in Hope, BC, resulting in a doubling of the Company's cultivation capacity in the province.

Mar 22, 2019 02:22 pm ET

IIROC Trading Halt - VIVO

VANCOUVER, March 22, 2019 /CNW/ - The following issues have been halted by IIROC:

Mar 21, 2019 02:05 pm ET

IIROC Trading Resumption - VIVO

VANCOUVER, March 21, 2019 /CNW/ - Trading resumes in:

Mar 21, 2019 02:00 pm ET

VIVO Cannabis™ announces Health Canada approval for Napanee expansion, doubling production capacity in Ontario

NAPANEE, ON, March 21, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received approval from Health Canada to begin cultivation in the expansion of its Vanluven Road facility in Napanee, resulting in a doubling of the Company's Ontario cultivation capacity. Cultivation in the expanded area will commence immediately.

Mar 21, 2019 01:26 pm ET

IIROC Trading Halt - VIVO

VANCOUVER, March 21, 2019 /CNW/ - The following issues have been halted by IIROC:

Mar 21, 2019 07:00 am ET

VIVO Cannabis™ Begins Australian Observational Trial

Study focuses on efficacy of medical cannabis in treating chronic pain Data and insights to drive future medical cannabis product development NAPANEE, ON, March 21, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") today announced the commencement of the Company's observational study on the use of cannabinoids as therapy for chronic pain (the "Study"). Led by a group of well-known pain specialists, the Study is taking place in Melbourne, Australia, and is expected to provide long-term (24 month) data with which to evaluate the efficacy of medical cannabis

Mar 05, 2019 06:00 am ET

VIVO Cannabis™ announces launch of new online store

One of the largest integrated online shopping platforms for medical cannabis consumers More than 40 cannabis strains and 100 SKUs available Offering VIVO's proprietary brands (Beacon Medical™ and Canna Farms™) alongside products from other licensed producers NAPANEE, ON, March 5, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), through its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), today announced the launch of Canna Farms' integrated online medical cannabis website.

Feb 19, 2019 06:00 am ET

VIVO Cannabis Announces Appointment of Vice President, Napanee Operations

NAPANEE, ON, Feb. 19, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announce the appointment of Gary McMullen as Vice President, Napanee Operations. Mr. McMullen will assume his position effective March 4, 2019.

Feb 11, 2019 06:00 am ET

VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals

Amendment to production license allows for sale of cannabis oil Products to be available through VIVO's Beacon Medical™ and Lumina™ brands Significantly expands product line for medical cannabis patients and adult-use consumers NAPANEE, ON, Feb. 11, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a licensed cannabis producer offering premium medical and adult-use products and services, today announces that the Company's subsidiary, ABcann Medicinals Inc. ("ABcann"), has received approval from Health Canada for its most recent license amendment request

Jan 07, 2019 07:00 am ET

VIVO Cannabis Announces Appointment of Dr. Richa Love as Chief Medical Officer

NAPANEE, ON, Jan. 7, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V:VIVO, OTCQX: VVICF)("VIVO" or the "Company"), a licensed cannabis producer offering premium medical and adult-use products and services through its wholly-owned subsidiaries, ABcann Medicinals Inc. ("ABcann") and Canna Farms Ltd. ("Canna Farms"), today announce the appointment of Dr. Richa Love, MD, LMCC, CCFP, as the Company's Chief Medical Officer.

Dec 21, 2018 07:00 am ET

VIVO Cannabis™ Retains National Capital Markets to Provide Investor Relations Services

NAPANEE, ON, Dec. 21, 2018 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that it has retained NATIONAL Capital Markets to provide investor relations and financial communications services.

Dec 18, 2018 07:00 am ET

VIVO Announces Appointment of President, European Operations

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce the appointment of Andreas Sander as President, European Operations, and Managing Director of ABcann Germany GmbH, VIVO’s German subsidiary. Mr. Sander...

Dec 12, 2018 07:00 am ET

VIVO Announces Stock Option Grants

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that it has granted, effective today, an aggregate of 2,790,500 stock options (each, an “Option”) to certain directors, officers, employees and consultants of...

Dec 04, 2018 07:00 am ET

Canna Farms Wins Top Reviewed Licensed Producer of the Year Award

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), was recognized as the Top Reviewed Licensed Producer of the Year at the recent...

Nov 30, 2018 07:00 am ET

VIVO Cannabis™ Reports Record Revenue for Q3 2018

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), a licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, ABcann Medicinals Inc. (“ABcann”) and Canna Farms Limited (“Canna Farms”), is...

Oct 30, 2018 07:00 am ET

Harvest Medicine Launches Free Medical Cannabis Telemedicine Platform

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), one of Canada’s fastest growing specialty medical cannabis...

Oct 23, 2018 10:44 am ET

VIVO Announces Initial $5 Million Strategic Investment in National Access Cannabis

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has agreed to make a $5 million strategic investment in National Access Cannabis Corp. (TSXV: META) (“NAC”), and commited to invest an additional...

Oct 23, 2018 07:00 am ET

Harvest Medicine Signs Agreement with Think Research to Improve Coordination of Medical Cannabis Care

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has signed an agreement with Think Research, a leading digital...

Oct 17, 2018 07:00 am ET

Harvest Medicine Continues National Expansion with Acquisition of Trauma Healing Centres

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has completed the acquisition of Trauma Healing Centres (“THC”)...

Oct 05, 2018 07:00 am ET

VIVO and Loyalist College Collaborate on Cannabis Applied Research Project

VIVO Cannabis Inc. (TSXV:VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”), through its wholly owned subsidiary ABcann Medicinals Inc., and Loyalist College’s Applied Research Centre for Natural Products and Medical Cannabis (ARC) have entered into an...

Oct 04, 2018 07:00 am ET

VIVO Partners with Pharmascience to Develop Novel Cannabis Products

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has entered into an agreement with Pharmascience Inc. (“Pharmascience”), a global pharmaceutical company based in Montreal that holds a Dealers...

Oct 03, 2018 07:00 am ET

VIVO Announces $5 million Strategic Investment and Supply Agreement with Westleaf

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has made a $5 million strategic investment in Westleaf Cannabis Inc. (“Westleaf”), which is intended to be used by Westleaf to advance the roll...

Sep 28, 2018 07:00 am ET

VIVO selects Green Hedge as Distribution Partner for Adult-Use Products

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has signed a multi-year agreement with national cannabis distributor, Green Hedge Education Distribution Services Ltd. (“Green Hedge”). Green...

Sep 27, 2018 07:00 am ET

VIVO Cannabis Inc. Upgrades to the OTCQX Best Market

VIVO Cannabis Inc. (TSX-V: VIVO; OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that is has qualified to trade on the OTCQX® Best Market. VIVO upgraded to OTCQX from the OTCQB® Venture Market. VIVO begins trading today on OTCQX...

Sep 26, 2018 07:00 am ET

VIVO Completes First New Seasonal Greenhouse

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has completed the construction of its first innovative seasonal “Airhouse”. The first of four planned Airhouses to be constructed in 2018 has...

Sep 25, 2018 07:00 am ET

Canna Farms Completes First Shipment of Recreational Cannabis

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Ltd. (“Canna Farms”) has fulfilled and shipped its first recreational cannabis purchase destined for the...

Sep 24, 2018 07:00 am ET

VIVO Cannabis Inc. Subscribes to Strainprint Technologies to Maximize Patient Treatment Experience

TORONTO, Sept. 24, 2018 /CNW/ - Strainprint, the leader in cannabis data and analytics, is pleased to announce that VIVO Cannabis Inc. (TSXV: VIVO) is the latest top tier Canadian licensed producer to subscribe to Strainprint Analytics. VIVO is a leading, vertically-integrated, cannabis business with a collection of premium brands targeting unique consumer segments and needs across both medical and recreational channels, both in Canada and other international markets.

Sep 24, 2018 07:00 am ET

VIVO Launches Beacon Medical Website, Covers the Excise Tax and Announces Affiliation with Strainprint

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce the launch of its Beacon Medical™ website, its coverage of the excise tax on cannabis purchases, and an affiliation with Strainprint Technologies Ltd....

Sep 07, 2018 07:00 am ET

Canna Farms Selected as a Supplier to Ontario Retail Cannabis Market

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), has completed an agreement with the Ontario Cannabis Store (the “OCS”) to supply...

Sep 04, 2018 07:00 am ET

REPEAT: VIVO Cannabis Completes Acquisition of Canna Farms

VIVO Cannabis Inc. (formerly ABcann Global Corporation) (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has closed its previously announced acquisition of 100% of the issued and outstanding shares of Canna Farms...

Aug 31, 2018 04:00 pm ET

You are here

VIVO Cannabis Inc. (V:VIVO*CA)

Business Focus: N/A